Unveiling the potential benefits of statins in medulloblastoma treatment: A promising therapeutic approach by Amir Modarresi Chahardehi, Aida Naseri, Esfandiar Mali, Leili Ziaei, Fatemeh Moradi, Fatemeh Teimourpour, Leila Tajik, Hossein Motedayyen, Mohammad Saeed Soleimani Meigoli, Reza Nasiri, Reza Arefnezhad, Fatemeh Rezaei-Tazangi

Get full text

Cost-Effectiveness Analysis of Crizanlizumab in Sickle Cell Disease in Iran by Marzieh Nosrati, Shadi Izadidehkordi, Shekoufeh Nikfar, Fatemeh Sadat Heydari

“…A decision-tree model was designed, followed by a cost-utility analysis for crizanlizumab in two separate scenarios, targeting not only monotherapy with crizanlizumab in SCD compared with placebo, but also crizanlizumab’s concomitant use with hydroxyurea compared with hydroxyurea. The study reports the outcomes from Iran’s healthcare system perspective. …”
Get full text